Categories: aggregated

The Trillion-Dollar Question: Why Big Pharma’s Monopoly Fights to Keep Cannabis Illegal?

A recent study published in Health Economics provides a smoking gun that prohibition apologists would prefer you ignore. Researchers found that cannabis legalization reduces prescription drug spending by approximately 6% in small group insurance markets, with the effect growing stronger over time. Translation: when people can legally access cannabis, they spend less money on Big Pharma’s products.

Jason

Share
Published by
Jason

Recent Posts

How to Maximize Cannabis Yield: 5 Croptober Myths & Proven Tactics

Every Croptober, growers waste time on folklore instead of physics. We break down the science…

9 hours ago

Cannabis voter guide to the 2026 midterm elections

Leafly's 2026 cannabis voter guide for the midterms is the only plan you need to…

2 days ago

Harvest road trip 2026: Emerald Triangle genetics to watch

Come along on an Emerald Triangle road trip with Lindsay MaHarry to see some of…

3 days ago

The DEA Approved an Ayahuasca Church—Can You Start a Cannabis Religion?

This month an Iowa church got what every sacramental-plant congregation dreams about: a path to…

3 days ago

The 5 Celebrities Who Could Force Washington to Legalize Cannabis Overnight

The cannabis industry does not need another study, another tax revenue report, or another state-level…

5 days ago

What If We Regulated Alcohol Like Cannabis? The Hypocrisy of Legal Weed Laws

A liquor-retail trade group argued that the state’s cannabis oversight is lax and should look…

5 days ago